PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

PROCEPT BioRobotics Corporation

TD Cowen analyst Josh Jennings reiterated a Buy rating on PROCEPT BioRobotics today and set a price target of $34.00. Jennings covers the Healthcar...

PROCEPT BioRobotics (PRCT) Gets a Buy from TD Cowen

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nkarta (NKTX), PROCEPT BioRobotics (PRCT) and Line...

Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), PROCEPT BioRobotics (PRCT) and Lineage Therap (LCTX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on PROCEPT BioRobotics (PRCT) and Incyte (INCY). PROCEPT BioRobotics...

Current Yield	N/A	Payout Ratio	N/A
Annual DPS	$0.00	Growth Streak	0 years
Ex-Dividend	Invalid Date	Pay Date	Invalid Date
Record Date	N/A	Declaration	N/A
Frequency	NA	Quarterly Est	$0.00

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PRCT	$27.45	-5.34%	1.45M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PRCT	$27.45	-5.3%	1.45M
3
4
5
6

PRCT

PRCT

Dividend Overview

Get PROCEPT BioRobotics Corporation Data in Excel

Get PROCEPT BioRobotics Corporation Data in Excel